Search Results 9511-9520 of 42345 for oral
Current use of exogenous hormones (i.e., oral progesterone). Participating Mayo Clinic locations. Study statuses change often. Please contact the study team ...
... Oral and thro...at cancer, Head and neck cancer, Skin cancer, Oropharyngeal cancer, Thyroid cancer, Laryngeal cancer, Hypopharyngeal cancer, Salivary gland ...
Patients randomized to GDC-0199+R will be given GDC-0199 daily (oral, target dose 400 mg) and will receive 6 cycles of rituximab infused intravenously (IV) ...
If your examination and test results can't confirm milk allergy, a healthcare professional might administer an oral challenge. In this test, you are fed ...
The risk typically arises from clots that may form in the left atrial appendage. Lifelong treatment with warfarin blood-thinning therapy or a direct oral ...
Oral gonadotropin-releasing hormone antagonists for the treatment of uterine leiomyomas. Obstetrics & Gynecology. 2023; doi:10.1097/AOG.0000000000005145 ...
Participants who are able to switch to low molecular weight heparin (LMWH) or direct oral anticoagulants (DOACs) prior to date of registration (and plan to ...
r, Oral and throat cancer, Mouth cancer, Thyroid cancer, Head and neck cancer, Salivary gland tumor, Soft palate cancer, Nasal and paranasal tumors ...
... Oral and throat cancer, Head and neck cancer, Skin cancer, Oropharyngeal cancer, Mouth cancer, Thyroid cancer, Melanoma, Squamous cell carcinoma of the skin ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.